United States · FDA National Drug Code directory

Levothyroxine sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-642_7a6abcab-a753-4c1d-92fb-c134ffc2c0a7
Product NDC
71205-642
Form
TABLET
Composition / generic term
Levothyroxine Sodium
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20201210
Source listing expiry
20261231

Source-listed ingredients

  • LEVOTHYROXINE SODIUM — 100 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (71205-642-30) · 71205-642-30
  • 60 TABLET in 1 BOTTLE (71205-642-60) · 71205-642-60
  • 90 TABLET in 1 BOTTLE (71205-642-90) · 71205-642-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →